Transplant Current Events | Page 3

Transplant Current Events, Transplant News Articles.
Sort By: Most Viewed | Most Recent
Page 3 of 25 | 1000 Results
Obese kidney transplant patients twice as likely to die in the first year or suffer organ failure
Six percent of obese kidney transplant patients die in the first year and 14 percent suffer transplant failures. The figures for non obese patients are three percent and eight percent. Experts from seven university hospitals in the Netherlands studied 2067 patients. Their finding appear in the November issue of Transplant International. (2006-11-13)

Study shows benefit of new maintenance therapy for multiple myeloma
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. Unfortunately, multiple myeloma continues to progress even after a transplant. A study published today in the New England Journal of Medicine offers promising news about a new long-term therapy, lenalidomide, that can be used after transplantation to slow down the progression of the disease. (2012-05-11)

Kidney transplants: White blood cells control virus replication
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines. (2017-03-30)

Many liver transplant candidates have deficits in physical activity that are missed by clinicians
A new study found that patients waiting for a liver transplant tend to be highly sedentary. Also, patients' self-assessments of their physical activity, and even their doctors' assessments, do not reliably indicate patients' actual physical performance. (2016-10-03)

Survival rates exceed national averages for UCSF heart, liver and lung transplant programs
One-year survival rates for patients receiving heart, liver and lung transplants at UCSF Medical Center exceed national averages at statistically significant levels, according to new data compiled by the Scientific Registry of Transplant Recipients. (2008-02-29)

Physicians can better predict outcomes for kidney transplant patients with key data, study finds
Kidney transplant patients have a better chance of survival if physicians use all the data that's available to them -- including data that's tracked over time -- to predict the likelihood of organ failure. (2017-01-06)

Substitution of brand name with generic drug proves safe for transplant recipients
A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of transplanted organs appears to be safe for transplant recipients. (2011-09-13)

Massachusetts General Hospital performs first-of-its-kind heart transplant in New England
Mass General Hospital recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death (DCD) donor hearts. (2020-01-10)

Approval to start US BTT pivotal trial
Ventracor has received approval from the US Food & Drug Administration to begin enrollment in the US Bridge To Transplant Pivotal Trial of the VentrAssist Left Ventricular Assist Device. (2007-04-04)

U of A researchers can predict heart transplant patient's health earlier
Michael Mengel, a pathology researcher with the Faculty of Medicine & Dentistry, has found a new way to analyze biopsies from heart transplant patients by looking at their genes. This allows him to make an early prediction whether the transplant is working. (2010-11-10)

Long-term outcomes for liver transplantation due to hepatitis C
A new study on liver transplants necessitated by the hepatitis C virus (the most common indication for this type of transplant) found that long-term outcomes are similar to patients receiving transplants due to other diseases. It was the first study to examine long-term transplantation results in hepatitis C patients and to identify risk factors that might lead to transplant failure or death. (2004-09-07)

Head & neck cancer in transplant patients: For better or worse?
Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study from Henry Ford Hospital in Detroit. (2012-01-27)

National Conference on Organ Donation and Transplantation
The National Committee for Quality Healthcare (NCQHC) is sponsoring a national conference, Organ Donation and Transplantation: A Commitment to Quality, with support from The Roche Foundation. Senior thought leaders and government officials will discuss key issues in organ donation and transplantation. (2002-11-15)

One-year kidney allograft outcomes do not differ by hepatitis C status of donor
Study published in AJKD shows that kidney allograft outcomes one year post-transplantation in hepatitis C virus (HCV)-negative recipients do not differ by the HCV status of the donor. (2020-12-14)

Cutting-Edge Discoveries In Transplantation To Be Revealed At National Medical Conference
The nation's leading transplant surgeons and researchers will present breakthrough therapies and technologies. (1999-05-11)

Mayo Clinic discovers one more downside to alcoholism
Mayo Clinic researchers have found nearly half of patients who underwent transplantation due to alcoholic-liver disease experienced an acute state of confusion after the operation. This short but severe confusion struck 48 percent -- or 19 of 40 -- alcoholic liver-disease patients compared with 6 percent -- or three out of 47 -- hepatitis C patients, another major group receiving liver transplant. The study is published in the Aug. 28, 2002, edition of Neurology. (2002-08-27)

Artery variations increase complication risk in liver transplants
3D MDCT angiography is a more efficient way to classify liver arterial anatomy before liver surgery, according to researchers from Duke University in Durham, NC. In a separate study, University of Iowa researchers have found that using MR angiography before a liver transplant can help identify which patients will suffer complications. The study found that if the liver artery anatomy is unusual, there is an increased risk of complications after the transplant procedure. (2004-12-02)

Use of opioid pain medications may affect liver transplant patients' survival
An analysis of nearly 30,000 patients undergoing liver transplantation in the United States between 2008 and 2014 found elevated death and organ loss rates in the first five years after transplantation among recipients with the highest use of opioid pain medications while on the waiting list. (2017-03-02)

What are risk factors for melanoma in kidney transplant recipients?
Kidney transplant patients appear to be at a greater risk of developing melanoma than the general population and risk factors include being older, male and white, findings that corroborate results demonstrated in other studies, according to a new article published by JAMA Dermatology. (2017-07-26)

Study shows steroid therapies following transplant can be eliminated
A new study by researchers at the University of Cincinnati shows that using modern immunosuppressive drugs eliminates the need for steroid therapy as early as seven days following a transplant surgery while still maintaining kidney function. (2008-10-21)

Age should not be a factor in determining heart transplantation eligibility, researchers say
Policy makers who use age as a discriminating factor in determining eligibility for heart transplant surgery may want to reconsider their rules in the light of new research at the University of Alberta. (2005-02-14)

UCLA's heart transplant program ranked among nation's best
The heart transplant program at Ronald Reagan UCLA Medical Center has again been recognized as one of highest ranking in the nation by an agency of the US Department of Health and Human Services. (2012-10-19)

Lifelong medicare coverage of transplant drugs would save money
Extending Medicare coverage of anti-rejection medications beyond 36 months after a kidney transplant would lead to lower costs and an improvement in patients' quality of life. Results from the study will be presented at ASN Kidney Week 2019 Nov. 5-10 at the Walter E. Washington Convention Center in Washington, D.C. (2019-11-07)

Race, insurance status related to likelihood of being assessed for kidney transplantation
Young black patients and patients without private health insurance are less likely to be assessed for a kidney transplant when they start dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology. (2012-07-26)

Lung transplantation: A treatment option in end-stage lung disease
In the past five years, the number of lung transplantations carried out has increased by about 20 percent. In the end stage of various lung diseases, transplantation is the last remaining option for treatment, and it can both prolong life and improve its quality. Marc Hartert and colleagues have studied how patients do after a lung transplant, and their review appears in the current edition of the Deutsches Aerzteblatt International. (2014-03-05)

Effect of distance from transplant center on outcomes
Among veterans meeting eligibility for liver transplantation, greater distance from a Veterans Affairs transplant center or any transplant center was associated with lower likelihood of being put on a waitlist or receiving a transplant, and a greater likelihood of death, according to a study in the March 26 issue of JAMA. (2014-03-25)

Henry Ford Hospital study: Donor Risk Index does not impact outcomes on a small scale
The Donor Risk Index, which assesses donor characteristics impacting liver transplantation outcomes, does not bear the same impact on outcomes on a small scale as is suggested from large-scale, national data. Rather, hepatitis C was shown to continue to be the major contributor to poor graft survival in transplant patients, according to a Henry Ford Hospital. (2010-08-16)

IU researcher publishes 'landmark' results for curing hepatitis C in transplant patients
A new treatment regimen for hepatitis C, the most common cause of liver cancer and transplantation, has produced results that will transform treatment protocols for transplant patients, according to research published online today in the New England Journal of Medicine. (2014-11-11)

Earlier not necessarily better when receiving a kidney transplant
Pre-dialysis transplant recipients with a high level of kidney function don't benefit from their transplant more than pre-dialysis recipients with low level kidney function, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, Calif. The findings indicate that there may be no urgency for kidney disease patients to get a transplant while their kidneys are still somewhat healthy. (2009-10-29)

New clinical prediction index to help patients considering kidney transplant
A new clinical prediction index has been developed to determine the risk of death in patients with end-stage kidney disease considering transplantation, states a Research article in CMAJ. (2010-03-29)

Sex differences and organ transplant rejection
In general, the influence of biological sex on transplant outcomes has not been rigorously studied and largely underappreciated. A new study by investigators at Brigham and Women's Hospital assesses what is currently known about the influence of biological sex differences, possible mechanisms that may explain discrepancies between rejection rates for male and female recipients and what questions remain to be explored in future studies. (2018-03-22)

UC to study generic vs. brand-name transplant drugs with a $2.7 million FDA grant
A new study at the University of Cincinnati seeks to end the questions over generic-vs.-brand for a common immunosuppressive drug for transplant patients, tacrolimus. Rita Alloway, PharmD, UC research professor of medicine, has received a $2.7 million US Food and Drug Administration grant to run a clinical trial studying the immunosuppressant tacrolimus against two other generic manufacturers in liver and kidney transplant patients. (2012-10-18)

UBC study: Kidney transplant chains more effective in saving lives
New research from the UBC Sauder School of the Business has found that transplant societies which prioritize kidney transplant chains over kidney exchanges can increase the total number of transplants, thereby saving more lives. (2018-08-09)

New Strategy May Succeed At Extending The Life Of Transplanted Kidneys
A kidney transplant offers people with kidney failure a new chance at a normal, active life. But, on average, a transplanted kidney continues to function for only nine years. Now, doctors at the University of Maryland Medical Center say a new strategy to extend the function of transplanted kidneys shows promise. (1999-05-16)

Mayo clinic: Long-term benefits to the liver-kidney transplant
A new study from physicians at Mayo Clinic in Rochester, found there may be long-term benefits to simultaneous liver-kidney transplantation versus kidney transplantation alone. (2016-04-15)

Liver transplant recipients almost 3 times more likely to develop cancer
Cancer incidence is higher among liver transplant recipients in Finland compared to the general population, according to a new study in the October issue of Liver Transplantation, a journal by John Wiley & Sons. (2008-10-02)

Aboriginal children less likely to receive kidney transplants
Aboriginal children with kidney failure were less likely to receive a kidney transplant compared to white children, found an article in CMAJ. (2011-05-24)

UM Doctors Show Ways To Improve Success Of Pancreas Transplants
In a new study, doctors at the University of Maryland Medical Center have shown that pancreas transplants alone can be as successful as combined pancreas/kidney transplants. The improved success rate is due to advances in preventing organ rejection and a better method of determining early rejection of the pancreas. The study is published in the October 7 issue of Annals of Surgery (1996-11-04)

New protocols in kidney- pancreas transplantation produces better results for patients
Due to refined surgical techniques and advances in anti-rejection therapy, transplant surgeons at the University of Pittsburgh's Thomas E. Starzl Transplant Institute are able to successfully perform a higher volume of kidney-pancreas transplants, -- more than 22 kidney-pancreas transplants in the past three months -- which yields a shorter wait time on the transplant list, a better graft survival and quicker recovery. (2004-09-29)

Heart, heart-lung and lung transplant recipients can have successful pregnancies
Women who have received a heart, heart-lung or lung transplant are having successful pregnancies after transplantation, according to a study by researchers at Jefferson Medical College. While such pregnancies are considered (2002-08-30)

Page 3 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to